Latest Stocks to Buy Updates:
Someone Watching Tonight Could Become a Millionaire
[Wednesday, April 29, 11:26 a.m.]
Contributed by Matt McCall
The cryptocurrency “Halvening” event will occur in the middle of May…
Which is just days from now.
This special situation will cut the amount of new bitcoins in HALF overnight.
But more importantly, it will send certain altcoins soaring higher than most people imagine possible.
The last time the Halvening event occurred four years ago, these extraordinary gains were seen in the altcoin market:
- Verge shot up 1,362,400%.
- Reddcoin soared 72,400%.
- And NEO rose 134,453%.
You must discover how to position yourself before this historic event takes place — and the biggest profits are made.
That’s why I’m making it easier than ever to join my Ultimate Crypto research service … and discover the full cryptocurrency model portfolio we’ve created.
For tonight only…
I’m giving all my readers an instant $2,000 savings off the normal Ultimate Crypto rate.
This means we’re cutting the price in more than half.
But this is important: This $2,000 discount is only available tonight.
To discover the full details, all you have to do is attend our online event, the 2020 Crypto Millionaire Summit.
It all happens tonight, April 29, at 7 p.m. ET. You don’t want to miss this…
Click here to reserve your spot for free.
Stocks Open Higher Even as GDP Contracts
[Wednesday, April 29, 9:31 a.m]
Contributed by Sarah Smith
Investors are gearing up for a good today, even as they learn GDP contracted by 4.8% in the first quarter. Perhaps that’s just not surprising — even though it came in worse than estimates.
Regardless, there’s a lot of green in the major indices today. The S&P 500, Dow Jones Industrial Average and the Nasdaq Composite all opened solidly higher.
- The S&P 500 opened higher by 1.92%
- The Dow Jones Industrial Average opened higher by 1.5%
- The Nasdaq Composite opened higher by 2.15%
3 Stocks That Will Benefit from Oil Storage Demand
[Tuesday, April 28, 3:40 p.m.]
Contributed by Sarah Smith
It’s no secret that crude oil storage — or the lack thereof — is driving the market. Last week, panic over the supply-demand imbalance sent crude oil prices negative. Stocks went tumbling, too.
But as research firm CFRA points out, there are winners in this chaos. Companies that are well-positioned in terms of storage capacity should see their stocks gain.
From CFRA analyst Stewart Glickman, via CNBC (subscription required):
“Firms with available storage space are going to fetch strong pricing, given too many producers are seeking places to shelve unneeded crude.”
So who are the winners? West Texas Intermediate, the U.S. benchmark for crude, is trading at $13 for June delivery. But later months are trading at higher prices, which incentivizes storage. With this logic, companies with the most storage space win.
Plains All American (NYSE:PAA) and NuStar (NYSE:NS) each have 10%-12% of the country’s storage capacity. Glickman is also hot on Phillips 66 (NYSE:PSX). Phillips 66 is most known for being in the refiner business, but it has 5.5% of U.S. storage capacity.
InvestorPlace’s Will Ashworth agreed with Glickman at the end of March. He included PSX stock on his list of the top 10 best value stocks to own for 2020. Ashworth says it’s simply a triple threat.
As oil continues to be in focus, keep an eye on these three stocks.
Meat Stocks Are Climbing on Trump’s Plan
[Tuesday, April 28, 1:51 p.m.]
Contributed by Sarah Smith
Smithfield Foods’ CEO warned of devastating impacts to the supply chain when his company was forced to close a pork plant in Sioux Falls, South Dakota. Over the weekend, Tyson Foods (NYSE:TSN) took out a full-page ad in The New York Times, declaring that meat plant closures were “breaking” the supply chain in the United States.
Certainly these CEOs were not the only ones worried about the U.S. supply chain. Higher prices for meat — and grocery store shortages — had many consumers afraid.
On Tuesday, President Donald Trump hinted at a major response to the meat problem. According to Bloomberg, he’s planning to use the Defense Production Act to keep meat-processing plants open. Because plants have closed as workers contracted Covid-19, the government would issue them additional personal protective equipment.
Prior to this announcement, estimates showed that as much as 80% of the country’s meat production could shut down. The Sioux Falls plant alone accounted for 5% of U.S. pork.
Investors like the news. TSN stock is up 6.4% in intraday trading, and JBS (OTCMKTS:JBSAY) stock is up 5.2% on the day.
Ignore the Pandemic Pseudoscience and Buy 5G Stocks
[Monday, April 27, 4:55 p.m.]
Contributed by Sarah Smith
InvestorPlace analyst Louis Navellier is fed up with the pandemic pseudoscience. Conspiracy theorists are claiming exposure to 5G radiation weakens the body’s immune system, making people more susceptible to the novel coronavirus.
But as Navellier writes, there’s no real science to that. And there’s definitely no science behind people burning down 5G cellular towers in Europe.
Pseudoscientists conveniently don’t take the time to explain that there’s two types of radiation — ionizing and non-ionizing. 5G technology relies on non-ionizing radiation. It can’t hurt you.
With that in mind, investors should get serious about major opportunities in 5G ahead, like Navellier’s favorite company in the space. This pick relies on radio-frequency technology and is set to profit off of every aspect of 5G.
So, don’t listen to the conspiracy theorists. Stay inside, stay safe. And if you’re ready to learn more about opportunities in 5G, read the rest of Navellier’s thoughts here.
Japan’s Plan to Approve Remdesivir Is a Catalyst for Gilead
[Monday, April 27, 4:38 p.m.]
Contributed by Sarah Smith
In his daily column, InvestorPlace’s Bret Kenwell highlighted a serious catalyst for Gilead Sciences (NASDAQ:GILD) stock. On Monday, Japanese news site Kyodo reported that Prime Minister Shinzo Abe is set to fast track approval for remdesivir. A different official said Monday remdesivir could be in use as early as next month to treat Covid-19.
Despite the good news, GILD stock closed higher by only 0.33% on Monday. For investors, remdesivir is still a critical treatment to watch, as trials are underway around the world.
Reuters reported Friday that key results from a U.S. trial could come as early as mid-May, and preliminary results could come sooner. This trial, led by the National Institute of Allergy and Infectious Diseases, began in February.
Coronavirus competitor Regeneron (NASDAQ:REGN) didn’t have the same fate today. Along with Sanofi (NYSE:SNY), the company announced that its Kevzara failed to show clinical benefits in Phase 2 and Phase 3 trials. REGN stock closed down by 3.3% on the day.